Literature DB >> 1544081

Guidelines for controlling meningococcal disease.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1544081      PMCID： PMC1488670     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  16 in total

1.  The risk of meningitis among classroom contacts during an epidemic of meningococcal disease.

Authors:  J A Jacobson; P A Camargos; J T Ferreira; J B McCormick
Journal:  Am J Epidemiol       Date:  1976-11       Impact factor: 4.897

2.  Efficacy of ciprofloxacin in the treatment of nasopharyngeal carriers of Neisseria meningitidis.

Authors:  M P Pugsley; D L Dworzack; E A Horowitz; T A Cuevas; W E Sanders; C C Sanders
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

3.  Serologic response to serogroup C meningococcal vaccine in Brazilian preschool children.

Authors:  V Amato Neto; H Finger; E C Gotschlich; R A Feldman; C A de Avila; S R Konichi; W C Laus
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1974 May-Jun       Impact factor: 1.846

4.  Single-dose ceftriaxone to eradicate pharyngeal Neisseria meningitidis.

Authors:  F N Judson; J M Ehret
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

Review 5.  Public health considerations in the management of meningococcal disease.

Authors:  J B McCormick; J V Bennett
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

6.  Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland.

Authors:  P H Mäkelä; H Peltola; H Käyhty; H Jousimies; O Pettay; E Ruoslahti; A Sivonen; O V Renkonen
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

7.  Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.

Authors:  R Gold; M L Lepow; I Goldschneider; T L Draper; E C Gotschlich
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

8.  Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.

Authors:  H Peltola; H Mäkelä; H Käyhty; H Jousimies; E Herva; K Hällström; A Sivonen; O V Renkonen; O Pettay; V Karanko; P Ahvonen; S Sarna
Journal:  N Engl J Med       Date:  1977-09-29       Impact factor: 91.245

9.  Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis.

Authors:  B Schwartz; A Al-Tobaiqi; A Al-Ruwais; R E Fontaine; J A'ashi; A W Hightower; C V Broome; S I Music
Journal:  Lancet       Date:  1988-06-04       Impact factor: 79.321

10.  Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts.

Authors:  P De Wals; L Hertoghe; I Borlée-Grimée; S De Maeyer-Cleempoel; G Reginster-Haneuse; A Dachy; A Bouckaert; M F Lechat
Journal:  J Infect       Date:  1981-03       Impact factor: 6.072
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.